Jiangsu Lanfeng Bio-chemical Co.,Ltd

Jiangsu Lanfeng Bio-chemical Co.,Ltd is engaged in the entire process of research, development, manufacturing, and distribution of agro-chemicals and specialty chemical intermediates. Serving both domestic and global markets, the company provides a wide range of crop protection products, including various pesticides, fungicides, insecticides, and herbicides. Key offerings within their product portfolio include thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The firm's operational base is located in Xinyi, China.

Jiangsu Lanfeng Bio-chemical Co.,Ltd trades as 002513.SZ on SHZ. The company is classified in Basic Materials / Chemicals and reports in CNY.

The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Jiangsu Lanfeng Bio-chemical Co.,Ltd can be compared against peers such as Gpro Titanium Industry Co., Ltd., Jointown Aesthetics ValleyCo.,Ltd. Class A, Ningxia Yinglite Chemicals Co., Ltd, Hubei Shuanghuan Science and Technology Stock Co.,Ltd, Jiangxi Selon Industrial Co., Ltd., Jiangsu Flag Chemical Industry Co., Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $2.13B, beta of 1.05, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

002513.SZ currently shows total debt of N/A and beta of 1.05. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.jslanfeng.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.